Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
about
The significance of FOXP1 in diffuse large B-cell lymphoma.Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysisFOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival iPleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy.
P2860
Q34047455-79E0DC5C-8FE3-4DBC-AC0A-455E941D20FDQ37125561-81E76571-8D01-4530-B69C-C5CF9B69ABBAQ37619689-8DE18380-B303-4209-B45B-1997504EFD90Q38795442-08B32590-83F7-4010-8EE8-88DCA183F64DQ38902828-CDEC34AB-0ABB-4C8E-B900-E926817B4D04Q40238236-1275F622-483C-4AE9-91F2-E6E144B46D54Q40400859-4F096C31-A8CC-4A3F-BF4D-5AAAA82D2EC3Q40415214-C2D422A0-A02B-4EB9-A09D-3527F639CA1AQ48027440-0961892D-E6B2-4CEB-B03C-67742AE7BC1DQ55106924-E8A07DE3-B901-40A8-970C-6388B7057C75
P2860
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@ast
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@en
type
label
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@ast
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@en
prefLabel
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@ast
Multiparameter analysis of hom ...... prospective SAKK 38/07 study.
@en
P2093
P2860
P50
P1476
Multiparameter analysis of hom ...... e prospective SAKK 38/07 study
@en
P2093
Christoph Mamot
Darius Juskevicius
Stephan Dirnhofer
P2860
P2888
P356
10.1186/S13045-015-0168-7
P577
2015-06-14T00:00:00Z
P5875
P6179
1012916517